BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35477031)

  • 1. Non-invasive methods for iron overload evaluation in dysmetabolic patients.
    Branisso PPF; de Oliveira CPMS; Filho HML; Lima FR; Santos AS; Mancini MC; de Melo ME; Carrilho FJ; Rocha MS; Clark P; Branisso HJP; Cercato C
    Ann Hepatol; 2022; 27(4):100707. PubMed ID: 35477031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
    Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
    Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
    BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?
    Rametta R; Fracanzani AL; Fargion S; Dongiovanni P
    Curr Pharm Des; 2020; 26(10):1025-1035. PubMed ID: 32003680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.
    Corradini E; Buzzetti E; Dongiovanni P; Scarlini S; Caleffi A; Pelusi S; Bernardis I; Ventura P; Rametta R; Tenedini E; Tagliafico E; Fracanzani AL; Fargion S; Pietrangelo A; Valenti LV
    J Hepatol; 2021 Sep; 75(3):506-513. PubMed ID: 33774058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin resistance in dysmetabolic iron overload.
    Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
    Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease.
    Buzzetti E; Petta S; Manuguerra R; Luong TV; Cabibi D; Corradini E; Craxì A; Pinzani M; Tsochatzis E; Pietrangelo A
    Liver Int; 2019 Jul; 39(7):1325-1334. PubMed ID: 30851216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
    Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
    An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
    Stechemesser L; Eder SK; Wagner A; Patsch W; Feldman A; Strasser M; Auer S; Niederseer D; Huber-Schönauer U; Paulweber B; Zandanell S; Ruhaltinger S; Weghuber D; Haschke-Becher E; Grabmer C; Rohde E; Datz C; Felder TK; Aigner E
    Mol Metab; 2017 Jan; 6(1):38-47. PubMed ID: 28123936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver iron concentration in dysmetabolic hyperferritinemia: Results from a prospective cohort of 276 patients.
    Castiella A; Urreta I; Zapata E; Zubiaurre L; Alústiza JM; Otazua P; Salvador E; Letamendi G; Arrizabalaga B; Rincón ML; Emparanza JI;
    Ann Hepatol; 2020; 19(1):31-35. PubMed ID: 31587985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.
    Valenti L; Dongiovanni P; Fargion S
    World J Gastroenterol; 2012 Aug; 18(29):3782-6. PubMed ID: 22876027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical evaluation of the role of iron overload in fatty liver disease.
    Fernandez M; Lokan J; Leung C; Grigg A
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1873-1883. PubMed ID: 35906772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of Liver Siderosis to Liver Fibrosis in Hemodialysis Patients With Severe Hyperferritinemia Secondary to High Doses of Intravenous Iron Supplementation.
    Ibrahim WH; Abokresha MM; Nigm DA; Abdelal SM; Kelani A; Aly MG
    J Ren Nutr; 2023 Mar; 33(2):337-345. PubMed ID: 36182059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperferritinemia in patients with nonalcoholic fatty liver disease.
    Barros RK; Cotrim HP; Daltro CH; Oliveira YA
    Rev Assoc Med Bras (1992); 2017 Mar; 63(3):284-289. PubMed ID: 28489136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
    Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperferritinemia and liver iron content determined with MRI: Reintroduction of the liver iron index.
    Moris W; Verbeek J; Bakers FC; Rombout-Sestrienkova E; Innocenti F; Masclee AAM; Koek GH; van Deursen CTBM
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102224. PubMed ID: 37813276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic iron is the major determinant of serum ferritin in NAFLD patients.
    Ryan JD; Armitage AE; Cobbold JF; Banerjee R; Borsani O; Dongiovanni P; Neubauer S; Morovat R; Wang LM; Pasricha SR; Fargion S; Collier J; Barnes E; Drakesmith H; Valenti L; Pavlides M
    Liver Int; 2018 Jan; 38(1):164-173. PubMed ID: 28679028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model.
    Hasebe T; Tanaka H; Sawada K; Nakajima S; Ohtake T; Fujiya M; Kohgo Y
    J Gastroenterol; 2017 Mar; 52(3):341-351. PubMed ID: 27364348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.